Literature DB >> 30525888

RORα nuclear receptors in protection against angiotensin II-induced cardiac hypertrophy.

Anna Zoccarato1, Ajay M Shah1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30525888      PMCID： PMC6397382          DOI： 10.1152/ajpheart.00732.2018

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN： 0363-6135            Impact factor:   4.733


× No keyword cloud information.
  18 in total

1.  Staggerer, a new mutation in the mouse affecting the cerebellum.

Authors:  R L SIDMAN; P W LANE; M M DICKIE
Journal:  Science       Date:  1962-08-24       Impact factor: 47.728

2.  Evidence for a hyperexcitability state of staggerer mutant mice macrophages.

Authors:  B Kopmels; J Mariani; N Delhaye-Bouchaud; F Audibert; D Fradelizi; E E Wollman
Journal:  J Neurochem       Date:  1992-01       Impact factor: 5.372

3.  The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response.

Authors:  P Delerive; D Monté; G Dubois; F Trottein; J Fruchart-Najib; J Mariani; J C Fruchart; B Staels
Journal:  EMBO Rep       Date:  2001-01       Impact factor: 8.807

4.  Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes.

Authors:  M Sano; K Fukuda; H Kodama; J Pan; M Saito; J Matsuzaki; T Takahashi; S Makino; T Kato; S Ogawa
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

5.  The nuclear receptor ROR(alpha) exerts a bi-directional regulation of IL-6 in resting and reactive astrocytes.

Authors:  Nathalie Journiac; Sarah Jolly; Christopher Jarvis; Vanessa Gautheron; Monique Rogard; Alain Trembleau; Jean-Paul Blondeau; Jean Mariani; Béatrice Vernet-der Garabedian
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-01       Impact factor: 11.205

6.  Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction.

Authors:  Lin Zhao; Guangming Cheng; Runming Jin; Muhammad R Afzal; Anweshan Samanta; Yu-Ting Xuan; Magdy Girgis; Harold K Elias; Yanqing Zhu; Arash Davani; Yanjuan Yang; Xing Chen; Sheng Ye; Ou-Li Wang; Lei Chen; Jeryl Hauptman; Robert J Vincent; Buddhadeb Dawn
Journal:  Circ Res       Date:  2016-04-28       Impact factor: 17.367

7.  Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha.

Authors:  A Mamontova; S Séguret-Macé; B Esposito; C Chaniale; M Bouly; N Delhaye-Bouchaud; G Luc; B Staels; N Duverger; J Mariani; A Tedgui
Journal:  Circulation       Date:  1998-12-15       Impact factor: 29.690

8.  The nuclear melatonin receptor RORα is a novel endogenous defender against myocardial ischemia/reperfusion injury.

Authors:  Ben He; Yichao Zhao; Longwei Xu; Lingchen Gao; Yuanyuan Su; Nan Lin; Jun Pu
Journal:  J Pineal Res       Date:  2016-02-16       Impact factor: 13.007

9.  Disruption of the nuclear hormone receptor RORalpha in staggerer mice.

Authors:  B A Hamilton; W N Frankel; A W Kerrebrock; T L Hawkins; W FitzHugh; K Kusumi; L B Russell; K L Mueller; V van Berkel; B W Birren; L Kruglyak; E S Lander
Journal:  Nature       Date:  1996-02-22       Impact factor: 49.962

10.  Retinoic Acid-Related Orphan Receptors (RORs): Regulatory Functions in Immunity, Development, Circadian Rhythm, and Metabolism.

Authors:  Donald N Cook; Hong Soon Kang; Anton M Jetten
Journal:  Nucl Receptor Res       Date:  2015-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.